Top View
- Phosphodiesterase Inhibitors in Acute Lung Injury: What Are the Perspectives?
- Celltransmissions Newsletter
- WHO-EMP-RHT-TSN-2018.1-Eng.Pdf
- A Controlled Trial of 6 Weeks' Treatment with a Novel Inhaled PDE4 Inhibitor
- (12) Patent Application Publication (10) Pub. No.: US 2005/0165041 A1 Hanauer Et Al
- Phosphodiesterase 11: a Brief Review of Structure, Expression and Function
- Study Protocol
- Advances in Targeting Cyclic Nucleotide Phosphodiesterases
- Assessment Report for Otezla
- Inhibition of Phosphodiesterase 4 Enhances Lung Alveolarisation in Neonatal Mice Exposed to Hyperoxia
- Known Bioactive Library: Selleck Bioactive 10Mm, 3.33Mm, 1.11Mm
- Research Journal of Pharmaceutical, Biological and Chemical Sciences
- PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2011) (Rev
- WO 2014/011955 A2 16 January 2014 (16.01.2014) P O P C T
- Effect of Roflumilast on Exacerbations in Patients with Severe Chronic
- Implications of PDE4 Structure on Inhibitor Selectivity Across PDE Families
- (19) United States (12) Patent Application Publication (10) Pub
- Roles of Roflumilast, a Selective Phosphodiesterase 4 Inhibitor, in Airway Diseases
- Customs Tariff - Schedule Xxi - 1
- Emerging Anti-Inflammatory Strategies for Chronic Obstructive Pulmonary Disease
- Acute Induction of Tracheo-Bronchoconstriction in Morphine/Chloralose Anesthetized Dogs: Physiological Approach and Principles of Therapy
- WO 2011/019399 Al
- 430 Adenosine, 71, 72, 217, 219, 223 2
- Phenotypic, Chemical and Functional Characterization of Cyclic Nucleotide Phosphodiesterase 4 (PDE4) As a Potential Anthelmintic Drug Target
- Phosphodiesterase Inhibitors Say NO to Alzheimer's Disease
- Literature Search Strategy for Treatment of Stable
- (51) International Patent Classification: (74) Agent: HARRIS, Bob Et Al.; Viksnins Flarris Padys Malen A61K 31/4725 (2006.01) A6
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Phosphodiesterase Inhibitors As a Therapeutic Approach to Neuroprotection and Repair
- Acylation 93 Adenosine Deaminase Inhibitor 83, 84 Α2-Adrenalceptor
- Evalua on of Human PDE4 Inhibitors Cilomilast and Piclamilast As Lead
- Cyclic Nucleotide Phosphodiesterases (Pdes) in Smooth Muscle : Expression, Function and Mechanism Kui Zhai
- Generation of Pharmacophores and Classification of Drugs Using Protein-Ligand Complexes
- WO 2017/033032 Al 2 March 2017 (02.03.2017) P O P C T
- Phosphodiesterases As Therapeutic Targets for Respiratory
- L:\0900\0900PHARMAPPX .Wpd
- Vanderbilt Evidence-Based Practice Center